Emergent BioSolutions can pursue chikungunya vaccine in Europe

Emergent BioSolutions Inc., a Gaithersburg life sciences firm that makes products to address public health threats, has an agreement with the European Medicines Agency to pursue its proposed development plan for a vaccine candidate.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *